Are all licensed hemostatic agents for hemophilia therapy accessible to patients? Letter to the Editor

Published Date

September 19, 2022

Authors

Berger K, Batorova A, Bohn RL, di Minno M, Mannucci P, Kavakli K, Schramm W, Aledort L on behalf of the International Prophylaxis Study Group

Citation

Haemophilia. 2022; 28:e256–e258. DOI: 10.1111/hae.14660